Jacobs & Co. CA Raises Holdings in Baxter International Inc (NYSE:BAX)
Jacobs & Co. CA lifted its holdings in shares of Baxter International Inc (NYSE:BAX) by 1.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 42,046 shares of the medical instruments supplier’s stock after buying an additional 765 shares during the period. Jacobs & Co. CA’s holdings in Baxter International were worth $3,443,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the company. SeaCrest Wealth Management LLC grew its holdings in Baxter International by 2.0% during the 2nd quarter. SeaCrest Wealth Management LLC now owns 6,117 shares of the medical instruments supplier’s stock valued at $501,000 after buying an additional 122 shares during the last quarter. Boston Private Wealth LLC grew its holdings in Baxter International by 1.8% during the 2nd quarter. Boston Private Wealth LLC now owns 7,346 shares of the medical instruments supplier’s stock valued at $602,000 after buying an additional 129 shares during the last quarter. Brookstone Capital Management grew its holdings in Baxter International by 4.0% during the 2nd quarter. Brookstone Capital Management now owns 3,422 shares of the medical instruments supplier’s stock valued at $280,000 after buying an additional 131 shares during the last quarter. Horrell Capital Management Inc. grew its holdings in Baxter International by 0.4% during the 1st quarter. Horrell Capital Management Inc. now owns 31,167 shares of the medical instruments supplier’s stock valued at $2,534,000 after buying an additional 138 shares during the last quarter. Finally, Cornerstone Advisors Inc. grew its holdings in Baxter International by 5.1% during the 2nd quarter. Cornerstone Advisors Inc. now owns 2,856 shares of the medical instruments supplier’s stock valued at $234,000 after buying an additional 139 shares during the last quarter. 83.96% of the stock is owned by institutional investors and hedge funds.
In other Baxter International news, insider Third Point Llc sold 5,000,000 shares of the firm’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $76.37, for a total value of $381,850,000.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Jacqueline Kunzler sold 593 shares of Baxter International stock in a transaction dated Wednesday, June 19th. The stock was sold at an average price of $80.46, for a total value of $47,712.78. Following the sale, the senior vice president now directly owns 9,023 shares in the company, valued at $725,990.58. The disclosure for this sale can be found here. Insiders sold 5,001,913 shares of company stock worth $382,000,950 over the last three months. 0.70% of the stock is currently owned by corporate insiders.
Baxter International stock traded down $1.53 during midday trading on Wednesday, reaching $86.65. The stock had a trading volume of 11,155 shares, compared to its average volume of 2,745,452. The firm has a 50-day moving average price of $83.32. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.78 and a quick ratio of 2.10. Baxter International Inc has a twelve month low of $61.05 and a twelve month high of $88.28. The stock has a market capitalization of $44.35 billion, a PE ratio of 28.54, a PEG ratio of 1.99 and a beta of 1.00.
Baxter International (NYSE:BAX) last released its quarterly earnings data on Thursday, July 25th. The medical instruments supplier reported $0.89 EPS for the quarter, beating the consensus estimate of $0.81 by $0.08. Baxter International had a return on equity of 21.21% and a net margin of 14.28%. The company had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.80 billion. During the same period last year, the company posted $0.77 earnings per share. The firm’s revenue was down .1% compared to the same quarter last year. Analysts predict that Baxter International Inc will post 3.37 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Shareholders of record on Friday, August 30th will be given a $0.22 dividend. This represents a $0.88 annualized dividend and a yield of 1.02%. The ex-dividend date of this dividend is Thursday, August 29th. Baxter International’s dividend payout ratio (DPR) is presently 28.85%.
About Baxter International
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.
Further Reading: Diversification For Individual Investors
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc (NYSE:BAX).
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.